Sign up Australia
Proactive Investors - Run By Investors For Investors

Provexis shares jump as it secures retail listing with Holland & Barrett for dietary product

The AIM-listed firm said Fruitflow+ Omega-3 is a two-in-one supplement in an easy to take capsule, supporting healthy blood flow and normal heart function
Holland & Barrett store
Holland & Barrett staff will be trained to understand and communicate the benefits of Fruitflow+ Omega-3 to prospective customers in store and online

Provexis PLC (LON:PXS) shares jumped on Monday as the food ingredient developer announced it has secured a retail listing with Holland & Barrett for its Fruitflow+Omega-3 dietary supplement product.

The AIM-listed firm said Fruitflow+ Omega-3 is a two-in-one supplement in an easy to take capsule, supporting healthy blood flow and normal heart function.

READ: Provexis launches new health supplement product

The product will be listed in August 2018 in more than 660 Holland & Barrett stores across the UK and Ireland, together with Holland & Barrett Online, giving widespread consumer exposure to the product and the company.

Provexis said Holland & Barrett staff will be trained to understand and communicate the benefits of Fruitflow+ Omega-3 to prospective customers in-store and online.

Dawson Buck, chairman of Provexis, said: “The listing will help raise awareness of the proven benefits of Fruitflow across a substantial consumer audience, and the company's expanding Fruitflow + dietary supplement business is expected to provide the company with an additional long-term income and profit stream.”

He added: “We look forward to working with Holland & Barrett to maximise recommendation, trial and repeat purchase of the product.”

In lunchtime trading, Provexis shares jumped 12.5% to 0.45p. 

View full PXS profile View Profile

Provexis Timeline

Newswire
December 22 2015

Related Articles

cake
April 17 2018
The group's major shareholders have staunchly supported the business while the AIM-listed group sorts out its financial position

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use